|
EP3245228A1
|
|
Human monoclonal antibodies against orexin receptor type 1
|
|
EP3247803A1
|
|
Methods for the diagnosis of pancreatic cancer
|
|
EP3242679A1
|
|
Methods and pharmaceutical compositions for the treatment of ischemic conditions
|
|
EP3234597A1
|
|
Proteins of the wnt signaling pathway and uses thereof in the diagnostic and treatment of hypopigmentation disorders
|
|
EP3212661A1
|
|
Cyclic antimicrobial pseudopeptides and uses thereof
|
|
EP3122898A1
|
|
New biomarker for outcome in aml patients
|
|
EP3119434A1
|
|
Tetrahydroquinoline derivatives and their use as epac1 inhibitors for the treatment of myocardial infarction injury
|
|
EP2741777A1
|
|
Methods and pharmaceutical compositions for treatment of pulmonary hypertension
|
|
EP2503997A1
|
|
Inhibitors of the pp1/gadd34 complex for the treatment of a condition requiring an immunosuppressive activity
|
|
EP2227560A1
|
|
Methods for the treatment and diagnosis of bone mineral density related diseases
|
